RxDoctor Payments DataLook up a doctor →

Amit Vora, MD

Interventional Cardiology · New Haven, CTNPI 1023270410

Payments from drug & device makers

$530,358in general payments, 2019–2025

Across 731 payments — averaging $725.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$379K
  • Inari Medical, Inc.$95K
  • Edwards Lifesciences$45K
  • Abbott$4K
  • E.r. Squibb & Sons, L.L.C.$3K
  • Boston Scientific$2K
  • plus $3K from 6 others
$22,841in research payments, 2019–2025

Across 6 payments — averaging $3806.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$23K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$530,358 in reported general payments places this provider in the 90th percentile of 73 interventional cardiology providers in Connecticut.

See all interventional cardiology providers in Connecticut

Medicare billing

Part B allowed, 2024
$119,762
Medicare patients
240
Services billed
552

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →